Introduction
============

Altitude hypoxia represents a formidable environmental challenge to the human organism. Hypoxia limits oxygen transport from the air to the muscle mitochondria, which compromises aerobic capacity (Calbet and Lundby [@b9]). Exercise capacity is a vital determinant of a population\'s ability to thrive at high altitude (Curran et al. [@b12]), and permanent residence above 5000 m poses problems for mining and other human endeavor. Despite more than a century of research on the detrimental effects of hypoxia on exercise performance, the exact underlying mechanisms remain poorly understood \[see (Amann and Kayser [@b4]; Verges et al. [@b56]) for reviews\].

Even though the cessation of maximal exercise, or the reduction in exercise intensity, when fatiguing, imply reduced motor recruitment by the central nervous system, the mechanisms that lead to the derecruitment of active muscle remain elusive. During normoxia and moderate hypoxia, leg muscle afferents appear to play an important role (Amann [@b2]; Amann and Dempsey [@b3]; Amann et al. [@b7]), whereas cerebral tissue oxygenation may play a more pivotal role under severe hypoxic conditions (Kjaer et al. [@b28]; Amann et al. [@b5]; Amann and Dempsey [@b3]; Subudhi et al. [@b50]*,* [@b52]; Rasmussen et al. [@b41]; Vogiatzis et al. [@b57]). At rest, the brain protects itself against hypoxia by increasing cerebral blood flow (CBF) to compensate for the decreased arterial oxygen tension (Cohen et al. [@b10]). But during high-intensity exercise, hyperventilation-induced hypocapnia leads to cerebral vasoconstriction, which counteracts the hypoxia-induced vasodilation, thereby lowering CBF and cerebral oxygenation (Jorgensen et al. [@b26]; Madsen et al. [@b32]; Ide et al. [@b23]; Subudhi et al. [@b51]). As hypoxia per se enhances ventilatory drive, this would further exacerbate the hyperventilation-induced hypocapnia during heavy exercise and further lower CBF and cerebral oxygenation. It was proposed that this reduction in cerebral oxygenation may account for the reduced performance during heavy exercise in severe hypoxia (Amann and Dempsey [@b3]; Nybo and Rasmussen [@b34]; Amann and Kayser [@b4]; Subudhi et al. [@b52]; Rasmussen et al. [@b41]). In support, reduced cerebral oxygenation has been shown to coincide with both reduced cortical motor output (Subudhi et al. [@b52]) and increased cerebral metabolism (Rasmussen et al. [@b41]).

Contrary to this hypothesis, Subudhi et al. ([@b53]) recently found exercise capacity to be *reduced* when they prevented the normal hyperventilation-induced hypocapnia with end-tidal CO~2~ clamping during incremental cycling in hypobaric hypoxia (equivalent of 4875 m), despite elevated CBF and improved cerebral oxygenation. They attributed this finding to limiting factors such as increased respiratory muscle work and associated "steal" of blood flow, and an elevated perceived effort related to their experimental setup, which may have outweighed the benefits of elevated cerebral O~2~ delivery. Siebenmann et al. ([@b48]) completed those observations by investigating, at a more moderate altitude (3454 m), the impact of clamping PETCO~2~ at 40 mmHg, on performance. Clamping increased middle cerebral artery velocity (MCAv), attenuated the decrease in cerebral oxygenation, but slightly decreased peak power output while it did not affect maximal oxygen uptake. Siebenmann et al. ([@b48]) concluded that although hypocapnia decreases CBF and cerebral oxygenation, this does not limit maximum aerobic exercise capacity. In contrast, using a similar approach but in nonacclimatized subjects during incremental exercise to capacity in more severe hypoxia (equivalent of 5000 m), we were unable to improve CBF with inspired CO~2~, despite a greater degree of hypercapnia (Fan and Kayser [@b61]). We attributed these discrepant findings to the different acclimatization states of the subjects in the different studies (389 m vs. 1600 m resident) and the type of hypoxia used (normobaric vs. hypobaric). However, all the aforementioned studies only looked at aerobic capacity using incremental exercise tests until voluntary exhaustion, which have limited ecological validity (Currell and Jeukendrup [@b13]). It thus remains unclear whether preventing a reduction in CBF and cerebral oxygenation associated with hyperventilation-induced hypocapnia would improve performance during prolonged, submaximal exercise paradigms such as time trial cycling, which are more representative of usual human exercise behavior.

In this study, we therefore examined the effect of clamping partial pressure of end-tidal CO~2~ (PETCO~2~) on CBF and performance during a 15-km time trial cycling in severe normobaric hypoxia, as time trial protocols provide a more accurate simulation of physiological responses during actual competitions (Foster et al. [@b15]) and has been shown to correlate well with actual race performance (Palmer et al. [@b36]). We tested the hypothesis that by preventing hyperventilation-induced hypocapnia, we would increase CBF and cerebral oxygen delivery without altering muscle tissue oxygenation during high-intensity exercise, improving exercise performance during 15-km time trial cycling at a simulated altitude of 5000 m in nonacclimatized low-altitude residents.

Methods
=======

Participants
------------

A power calculation was employed using a difference worth detecting of a 5% improvement in 15-km time trial cycling performance based upon previous findings by Jeukendrup et al. ([@b24]), along with unpublished data from our laboratory. A sample size of nine control volunteers was sufficient to give a power of 0.80 and an α of 0.05. Ten healthy males with a mean age of 27 ± 7 year (mean ± SD), a body mass index of 22.3 ± 1.3 kg/m^2^, VO~2~max of 63.3 ± 6.6 mL/min^/^kg, and maximal power output of 385 ± 30 W participated in this study. Participants were nonsmokers, had no previous history of cardiovascular, cerebrovascular, or respiratory disease and were not taking any medication. All participants were informed regarding the procedures of this study, and informed consent was given prior to participation. All the participants were residents of Geneva, Switzerland (\<500 m), and were trained cyclists. The study was approved by the Research Ethical Committee of the University Hospitals of Geneva and conformed to the standards set by the *Declaration of Helsinki*.

Experimental design
-------------------

The participants visited the laboratory on five occasions. Following full familiarization, which included a VO~2~max test to assess the participant\'s aerobic fitness (visit one), the participants underwent four experimental trials (randomized, balanced order, and in single-blind fashion) which consisted of the following conditions: (i) control normoxia (389 m); (ii) normoxia with CO~2~ clamping; (iii) control normobaric hypoxia (FIO~2~ = 0.10; simulated altitude of 5000 m); and (iv) normobaric hypoxia with CO~2~ clamping. Before each experimental session, the participants were asked to abstain from caffeine for 12 h, and heavy exercise and alcohol for 24 h. Each experimental testing session comprised of 20-min instrumentation with the participants breathing room air while seated on a bicycle fitted to a Computrainer Pro Model trainer, calibrated according to the manufacturer\'s instructions (RacerMate, Seattle, WA). While breathing normal room air, 4-min baseline data were collected (room air baseline), the participants then performed a 5-min self-selected warmup exercise (heart rate \<120 bpm). They were then switched to breathe from a modified gas mixing system (Altitrainer, SMTec, Nyon, Switzerland) followed by an additional 4-min resting baseline collection (condition baseline). The participants then did a 15-km time trial cycling as fast as possible. They were free to shift gears during the time trials, and constant feedback regarding the distance covered, but not speed, was provided on a computer screen (Computrainer™ 3D software version 3.0; Racermate). To prevent excessive thermal stress during the time trial exercise, two ventilators were placed ∼60 cm in front of the participants and wind velocity was adjusted according to cycling speed. Throughout each experimental session, the participants wore a nose clip and breathed through a mouthpiece attached to a low-resistance one-way nonrebreathing valve (Hans-Rudolph 2700, Kansas City, MO). The simulated normobaric hypoxia and CO~2~ clamping were achieved using the gas mixing system, which was attached to the inspiratory valve of the mouthpiece using a piece of large-bore low-resistance tubing. The device consists of a reservoir in which air and experimental gases are mixed and from which the participant inspires. This setup enables bleeding additional CO~2~ into the inspired gas mixture, thereby increasing the fraction of inspired CO~2~ (FICO~2~) while keeping the fraction of inspired O~2~ (FIO~2~) constant at either 0.21 (as in ambient air) or 0.10 (in Geneva the equivalent of an altitude of ∼5000 m) during normoxia and hypoxia conditions, respectively. PETCO~2~ clamping was achieved under feedback of on-screen PETCO~2~ (LabChart 7.2; ADInstruments, Colorado Springs, CO), continuously adapting FICO~2~ keeping PETCO~2~ to its target value (45 mmHg). The participants breathed through the same circuit in all four conditions and were unaware to what gas mixture they were breathing and naive to the exact rationale of the study. For each participant, the experiments were carried out at the same time of day under consistent laboratory conditions (temperature 21 ± 1°C, humidity 32 ± 5%, barometric pressure 726 ± 6 mmHg).

Measurements
------------

### Respiratory variables

Gas exchange was monitored on a breath-by-breath basis (Medgraphics CPX, Loma Linda, CA) measuring flow at the mouth with a Pitot tube and the fractions of inspired and expired O~2~ and CO~2~ with fast responding gas analyzers (infrared and paramagnetic) integrated in the system. Ventilation (V\'E) was derived from the flow signal and expressed in body temperature, pressure, saturated and per minute. The partial pressures of end-tidal O~2~ (PETO~2~) and CO~2~ (PETO~2~) were derived from the expired O~2~ and CO~2~ signals. Prior to each experimental session, the system was calibrated using a 3-L syringe (M9474; Medikro Oy, Finland) and precision gas mixtures of known O~2~ and CO~2~ concentrations (Carbogas AG, Gümligen, Switzerland).

### Cerebrovascular and cardiovascular variables

Middle cerebral artery velocity (as an index of CBF) was measured bilaterally in the middle cerebral arteries using a 2-MHz pulsed Doppler ultrasound system (ST3; Spencer technology, Seattle, WA). The ultrasound probes were positioned over the temporal windows and held firmly in place with an adjustable headband (Marc 600 Head Frame; Spencer Technology). The signals were obtained by first locating the bifurcation of the middle and anterior cerebral artery; the angle and depth of insonation were then adjusted to obtain measurements from the MCA. The insonation depth and the velocity of MCA signals were recorded and compared to ensure within-subject repeatability of MCAv measurements between trials. In our hands, day-to-day reproducibility of MCAv has a coefficient of variation of \<10%. The bilateral MCAv was averaged to represent global CBF during rest and exercise. Cerebral O~2~ delivery (cerebral DO~2~) was calculated using the equation: cerebral DO~2~ = mean MCAv × arterial oxygen content (CaO~2~, see below). Cerebral DO~2~ was normalized to the room air baseline values prior to 5-min warmup during each trial and expressed as %.

Cerebral oxygenation in the left prefrontal lobe was assessed by monitoring changes in oxy- (O~2~Hb), deoxy- (HHb), and delta (delta Hb: O~2~Hb--HHb) hemoglobin obtained with spatially resolved, continuous wave near-infrared spectroscopy (NIRS; Artinis Oxymon, MKIII, Zetten, the Netherlands). Source detector spacing was set at 4.1 cm and data obtained from the optode were used to calculate changes in O~2~Hb and HHb with a differential pathlength factor (DPF) calculated using the formula: DPF = 4.99 + 0.067 × (age^0.814^) (Duncan et al. [@b14]). Muscle oxygenation in the left vastus lateralis (∼15 cm proximal and 5 cm lateral to the superior border of the patella) was measured with an additional NIRS channel on the same instrument using a source detector spacing of 3.8 cm and DPF of 4.0 (Duncan et al. [@b14]). The cerebral and muscle O~2~Hb and HHb are expressed at absolute changes from room air baseline prior to the 5-min warmup period. Beat-to-beat mean arterial blood pressure (MAP) was monitored using finger plethysmography (Finometer® MIDI, Finapress Medical Systems, Amsterdam, the Netherlands). Peripheral O~2~ saturation (SpO~2~) was measured using earlobe pulse oximetry (Radical-7; Masimo Corporation, Irvine, CA).

### Blood gas variables

Arterialized earlobe capillary blood samples were taken at rest and every 5 km during exercise (Mollard et al. [@b33]). Vasodilating cream was applied to the earlobe 5 min prior to the sampling (Decontractyl, Sanofi Aventis, France). A lancet was used to pierce the earlobe and 60-μL capillary tubes (MultiCap; Siemens Healthcare Diagnostics Inc, Tarrytown, UK) were used to collect the samples. All samples were analyzed immediately (\<5 sec) using an arterial blood gas analyzing system (Rapidlab™ 248; Siemens Healthcare Diagnostics Inc) for arterialized capillary pH, partial pressure of arterialized capillary O~2~ (PcO~2~) and CO~2~ (PcCO~2~), and arterialized O~2~ saturation (ScO~2~). Standard calibration was performed prior to each blood sample analysis. Arterialized hemoglobin concentration (\[Hb\]) was measured using an azidemethemoglobin double wavelength photometer method (HemoCue® Hb201+; HemoCue AB, Ängelholm, Sweden). Arterialized capillary O~2~ content (CcO~2~; index of CaO~2~) was calculated using the equation: 1.36 × \[Hb\] × ScO~2~/100) + 0.003 × PaO~2~.

### Electromyography

Quadriceps electromyogram (EMG) was recorded from the right vastus lateralis during exercise using electrodes with full-surface solid adhesive hydrogel. Following careful preparation of the skin (shaving, abrading, and cleaning with alcohol) to lower impedance \<5 kΩ, pairs of circular silver chloride (recording diameter of 10 mm) surface electrodes (Medi-Trace™ 100; Tyco Healthcare Group, Mansfield, UK) with an interelectrode distance (center-to-center) of 20 mm were placed along the line from the superior lateral side of the patella to the anterior superior iliac spine at ∼100 mm from the patella as described by Rainoldi et al. ([@b39]). The position of the electrodes was marked on the skin for identical placement between exercise sessions. To minimize movement artifacts, the electrodes and cables were secured to the participant\'s leg using elastic bandage and netting. The EMG signals were amplified (Bio Amp Powerlab 26T; ADInstruments, Bella Vista, Australia) and filtered using a band-pass filter with low-pass cutoff frequency of 10 Hz and a high-pass cutoff frequency of 999 Hz (LabChart version 7.2; ADInstruments). The filtered EMG signals were sampled at 2 kHz by an analog-to-digital converter (PowerLab 26T; ADInstruments). As an index of motor drive, the EMG root mean square (RMS) was calculated for each single muscle contraction (LabChart version 7.2; ADInstruments).

### Rate of perceived exertion (RPE)

During exercise, the participants were asked to score their RPE on the 0--10 Borg scale every 3 km (Borg [@b60]). The scale with descriptors was mounted in front of the subject at eye height. At regular intervals they were asked to activate a handle bar mounted switch, activating the appropriate led indicator next to the descriptor corresponding to their RPE, resulting in a corresponding voltage signal being fed into the analog-to-digital converter.

Data and statistical analysis
-----------------------------

Resting values were obtained by averaging the data obtained in the last 30 sec of the 4 min resting period prior to exercise. During the time trial exercise, a single time-weighted mean value for each variable was obtained by averaging the means of the last 20 sec of each km. The effects of hypoxia and CO~2~ clamping on cardiorespiratory, cerebrovascular, and blood gas responses at rest were assessed using a two-way repeated measures ANOVA with α-level of 0.05 (IBM SPSS Statistics version 20.0; IBM Corporation, Armonk, NY). Likewise, we performed two-way repeated measures ANOVA to isolate the effect of hypoxia and CO~2~ clamping on the mean cardiorespiratory, cerebrovascular, and blood gas responses during the 15-km time trial cycling with a α-level of 0.05. Trends were considered when *P* \< 0.10. For significant interactions between hypoxia and CO~2~ clamping, four pairwise comparisons (Bonferroni corrected) were performed to isolate the effect of hypoxia and inspired CO~2~ on the dependent measures within participants with a α level of 0.0125, indicated where appropriate with the superscript ^B^. With the exception of RPE, which is reported as median and range, all data are reported as means ± SD.

With the exception of missing data at the end of exercise, which were replaced by repeated imputation using the missing data analysis function from the SPSS program, individual missing data points were replaced by values derived from a linear interpolation procedure.

Results
=======

All 10 participants completed the experimental protocol. Due to a technical problem, one participant could not complete the final 2 km during the CO~2~ clamping in hypoxia. Accordingly, comparison of exercise time was carried out in nine participants. Due to technical issues, blood sample analysis could not be carried out in all the participants (see [Table 2](#tbl2){ref-type="table"} for details). No participants reported any side effects such as headache or dyspnea following the experiments.

###### 

Effect of hypoxia and CO~2~ clamping on resting respiratory, cerebrovascular, and cardiovascular variables

                                              Normoxia      Hypoxia                                                                                    
  ------------------------------------------- ------------- --------------------------------------------- -------------------------------------------- -----------------------------------------------------------------------------
  Respiratory                                                                                                                                          
   V\'E (L/min)                               15.7 ± 2.6    22.3 ± 3.3[1](#tf1-1){ref-type="table-fn"}    16.6 ± 5.9                                   30.4 ± 4.4[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
   PETCO~2~ (mmHg)                            42 ± 2        45 ± 2[1](#tf1-1){ref-type="table-fn"}        37 ± 1[2](#tf1-2){ref-type="table-fn"}       46 ± 1[1](#tf1-1){ref-type="table-fn"}
   PETO~2~ (mmHg)                             108 ± 2       118 ± 5[1](#tf1-1){ref-type="table-fn"}       47 ± 2[2](#tf1-2){ref-type="table-fn"}       59 ± 2[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
   SpO~2~ (%)                                 97.1 ± 1.6    97.2 ± 1.5                                    83.5 ± 3.7[2](#tf1-2){ref-type="table-fn"}   89.1 ± 3.1[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
  Cerebrovascular                                                                                                                                      
   Middle cerebral artery velocity (cm/sec)   60 ± 6        61 ± 7[1](#tf1-1){ref-type="table-fn"}        61 ± 4[2](#tf1-2){ref-type="table-fn"}       69 ± 7[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
   Cerebral O~2~Hb (▵μmol)                    3.3 ± 3.4     3.4 ± 3.9                                     −1.4 ± 3.9[2](#tf1-2){ref-type="table-fn"}   1.3 ± 2.3[2](#tf1-2){ref-type="table-fn"}
   Cerebral HHb (▵μmol)                       −0.5 ± 0.7    −0.9 ± 1.8                                    4.9 ± 2.4[2](#tf1-2){ref-type="table-fn"}    2.3 ± 1.6[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
   Cerebral DO~2~ (%) *n* = 8                 101.7 ± 4.3   106.0 ± 8.3[1](#tf1-1){ref-type="table-fn"}   91.5 ± 8.7                                   109.3 ± 9.7[1](#tf1-1){ref-type="table-fn"}
  Muscle oxygenation                                                                                                                                   
   Muscle O~2~Hb (▵μmol)                      2.3 ± 4.1     1.8 ± 6.9                                     −3.7 ± 4.8[2](#tf1-2){ref-type="table-fn"}   −0.1 ± 5.0[2](#tf1-2){ref-type="table-fn"}
   Muscle HHb (▵μmol)                         −5.5 ± 2.7    −4.8 ± 3.9                                    −0.4 ± 6.4[2](#tf1-2){ref-type="table-fn"}   −2.2 ± 3.2[2](#tf1-2){ref-type="table-fn"}
  Cardiovascular                                                                                                                                       
   Mean arterial blood pressure (mmHg)        97 ± 6        101 ± 13                                      100 ± 8                                      106 ± 11
   HR (b/min)                                 80 ± 10       81 ± 11[1](#tf1-1){ref-type="table-fn"}       92 ± 16[2](#tf1-2){ref-type="table-fn"}      86 ± 10[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
  Blood gases                                                                                                                                          
   pH                                         7.46 ± 0.03   7.46 ± 0.05                                   7.48 ± 0.06                                  7.46 ± 0.04[1](#tf1-1){ref-type="table-fn"}
   PcCO~2~ (mmHg) *n* = 9                     34 ± 3        36 ± 3[1](#tf1-1){ref-type="table-fn"}        29 ± 3[2](#tf1-2){ref-type="table-fn"}       37 ± 56[1](#tf1-1){ref-type="table-fn"}
   [Pc]{.smallcaps}O~2~ (mmHg) *n* = 9        98 ± 5        107 ± 8[1](#tf1-1){ref-type="table-fn"}       46 ± 4[2](#tf1-2){ref-type="table-fn"}       57 ± 5[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
   ScO~2~ (%) *n* = 9                         97.9 ± 0.5    98.1 ± 0.3                                    87.2 ± 4.5[2](#tf1-2){ref-type="table-fn"}   90.9 ± 1.9[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}
   CcO~2~ (mL O~2~/dL) *n* = 9                19.9 ± 1.2    19.9 ± 1.3                                    17.8 ± 1.7[2](#tf1-2){ref-type="table-fn"}   18.5 ± 1.1[2](#tf1-2){ref-type="table-fn"}

Values are mean±SD. Cerebral and muscle oxygenation data (O~2~Hb and HHb) are expressed as delta change from baseline room air breathing values. Likewise, cerebral DO~2~ is expressed as % of baseline room air breathing values.

Different from control (*P* \< 0.05).

Different from normoxia (*P* \< 0.05).

###### 

Effect of hypoxia and CO~2~ clamping on arterialized blood gas variables and cerebral O~2~ delivery during 15-km time trial

                                Normoxia       Hypoxia                                                                                       
  ----------------------------- -------------- ---------------------------------------------- ---------------------------------------------- -------------------------------------------------------------------------------
  pH (*n* = 9)                                                                                                                               
   5 km                         7.42 ± 0.08    7.38 ± 0.07                                    7.40 ± 0.10                                    7.40 ± 0.06
   10 km                        7.41 ± 0.07    7.39 ± 0.10                                    7.41 ± 0.08                                    7.43 ± 0.04
   15 km                        7.39 ± 0.06    7.37 ± 0.07                                    7.39 ± 0.09                                    7.35 ± 0.07
  PcCO~2~ (mmHg) *n* = 9                                                                                                                     
   5 km                         32.0 ± 4.2     34.5 ± 3.2[1](#tf2-1){ref-type="table-fn"}     22.4 ± 2.5[2](#tf2-2){ref-type="table-fn"}     34.5 ± 3.1[1](#tf2-1){ref-type="table-fn"}
   10 km                        29.6 ± 2.5     33.7 ± 3.2[1](#tf2-1){ref-type="table-fn"}     19.8 ± 4.7[2](#tf2-2){ref-type="table-fn"}     34.2 ± 2.6[1](#tf2-1){ref-type="table-fn"}
   15 km                        27.6 ± 3.3     33.6 ± 4.1^1^                                  19.3 ± 3.1[2](#tf2-2){ref-type="table-fn"}     35.1 ± 3.0[1](#tf2-1){ref-type="table-fn"}
  PcO~2~ (mmHg) *n* = 8                                                                                                                      
   5 km                         81.2 ± 8.2     86.9 ± 10.7[1](#tf2-1){ref-type="table-fn"}    32.7 ± 4.8[2](#tf2-2){ref-type="table-fn"}     37.7 ± 2.9[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
   10 km                        82.1 ± 9.0     87.2 ± 9.3[1](#tf2-1){ref-type="table-fn"}     34.2 ± 3.3[2](#tf2-2){ref-type="table-fn"}     38.8 ± 3.0[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
   15 km                        82.7 ± 9.7     93.0 ± 17.5[1](#tf2-1){ref-type="table-fn"}    33.6 ± 4.2[2](#tf2-2){ref-type="table-fn"}     39.0 ± 3.8[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
  ScO~2~ (%) *n* = 7                                                                                                                         
   5 km                         95.4 ± 1.6     95.5 ± 2.2                                     64.4 ± 5.3[2](#tf2-2){ref-type="table-fn"}     68.6 ± 7.3[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
   10 km                        95.5 ± 1.8     96.4 ± 2.0                                     65.3 ± 3.4[2](#tf2-2){ref-type="table-fn"}     69.7 ± 6.0[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
   15 km                        95.7 ± 1.8     96.6 ± 2.1                                     65.8 ± 6.7[2](#tf2-2){ref-type="table-fn"}     68.4 ± 8.5[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
  CcO~2~ (mL O~2~/dL) *n* = 7                                                                                                                
   5 km                         19.5 ± 1.3     19.3 ± 1.5                                     13.1 ± 1.6[2](#tf2-2){ref-type="table-fn"}     14.0 ± 1.0[2](#tf2-2){ref-type="table-fn"}
   10 km                        19.6 ± 1.5     19.5 ± 1.4                                     13.3 ± 1.1[2](#tf2-2){ref-type="table-fn"}     14.3 ± 0.8[2](#tf2-2){ref-type="table-fn"}
   15 km                        19.6 ± 1.2     19.4 ± 1.4                                     12.7 ± 1.1[2](#tf2-2){ref-type="table-fn"}     14.0 ± 1.4[2](#tf2-2){ref-type="table-fn"}
  Cerebral DO~2~ (%) *n* = 7                                                                                                                 
   5 km                         115.5 ± 10.7   122.1 ± 13.2[1](#tf2-1){ref-type="table-fn"}   94.5 ± 9.7[2](#tf2-2){ref-type="table-fn"}     111.8 ± 11.8[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
   10 km                        116.4 ± 11.4   137.8 ± 38.8[1](#tf2-1){ref-type="table-fn"}   102.0 ± 11.1[2](#tf2-2){ref-type="table-fn"}   117.8 ± 9.6[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}
   15 km                        117.4 ± 12.9   150.3 ± 37.3[1](#tf2-1){ref-type="table-fn"}   99.5 ± 7.7[2](#tf2-2){ref-type="table-fn"}     122.9 ± 13.6[1](#tf2-1){ref-type="table-fn"},[2](#tf2-2){ref-type="table-fn"}

Values are mean±SD. Cerebral DO~2~ expressed as % of baseline room air breathing values.

Different from control (*P* \< 0.05).

Different from normoxia (*P* \< 0.05).

Resting variables
-----------------

### Respiratory variables

CO~2~ clamping elevated resting V\'E during normoxic and hypoxic conditions (*P* \< 0.001) ([Table 1](#tbl1){ref-type="table"}). Meanwhile, acute hypoxia had a greater effect on V\'E during the clamped condition compared to the unclamped condition (interaction: *P* = 0.028). Post hoc analysis showed that acute hypoxia elevated V\'E during CO~2~ clamping (*P* = 0.001^B^ vs. normoxia), but not during the unclamped control condition (*P* = 0.210^B^ vs. normoxia). There was an interaction between the effect of hypoxia and CO~2~ clamping on both PETCO~2~ and SpO~2~ (interaction: *P* \< 0.001 for both). As such, CO~2~ clamping elevated PETCO~2~ during both normoxic and hypoxic conditions (post hoc: *P* = 0.001^B^ and *P* \< 0.001^B^, respectively), whereas acute hypoxia lowered PETCO~2~ during the unclamped control condition (*P* \< 0.001^B^) and only tended to lower it during the clamped condition (*P* = 0.098^B^). Post hoc analysis revealed that resting SpO~2~ was lowered by acute hypoxia during both control and clamped conditions (*P* \< 0.001^B^ vs. normoxia), whereas CO~2~ clamping selectively elevated SpO~2~ in hypoxia (*P* = 0.002^B^), but not during normoxia (*P* = 0.713^B^). Acute hypoxia lowered resting PETO~2~ (*P* \< 0.001), whereas CO~2~ clamping elevated it (*P* \< 0.001).

### Cerebrovascular variables

Both acute exposure to hypoxia and CO~2~ clamping elevated resting MCAv (main effects: *P* = 0.014 and *P* \< 0.001, respectively; interaction: *P* = 0.101). Hypoxia at rest lowered cerebral O~2~Hb (*P* = 0.003), whereas CO~2~ clamping had no effect (*P* = 0.222). Hypoxia enhanced the effect of CO~2~ clamping on resting cerebral HHb (interaction: *P* = 0.047). Post hoc tests showed that hypoxia elevated cerebral HHb during control and clamped condition (*P* \< 0.001^B^ and *P* = 0.001^B^, respectively), whereas CO~2~ clamp lowered resting cerebral HHb in hypoxia (*P* = 0.001^B^) but not in normoxia (*P* = 0.579^B^). Resting cerebral DO~2~ was unaltered with hypoxia (*P* = 0.227), whereas CO~2~ clamping elevated it (*P* \< 0.001) with a trend for this increase to be greater in hypoxia compared to normoxia (interaction: *P* = 0.090). As a result, CO~2~ clamping in hypoxia restored resting cerebral DO~2~ to normoxic values (post hoc: *P* = 0.821^B^ vs. normoxia).

### Muscle oxygenation

Acute hypoxia lowered resting muscle O~2~Hb and elevated muscle HHb (hypoxia: *P* = 0.024 and *P* = 0.007, respectively), whereas no effect was observed with CO~2~ clamping (clamp: *P* = 0.301 and *P* = 0.602).

### Cardiovascular variables

Resting HR was higher with acute hypoxia (*P* = 0.001) and lower with CO~2~ clamping (*P* = 0.050, interaction: *P* = 0.085), whereas no differences were observed in MAP with either hypoxia or CO~2~ clamping (main effects: *P* = 0.128 and *P* = 0.136, respectively).

### Blood gas variables

No differences were observed in resting pH in hypoxia (*P* = 0.508), whereas there was an interaction between the effects of CO~2~ clamping and hypoxia on pH (interaction: *P* = 0.016) despite a lack of effect of CO~2~ clamp per se (*P* = 0.489). Post hoc analysis revealed that pH was lower with CO~2~ clamping in hypoxia (*P* \< 0.001^B^ vs. control), but not during normoxia (*P* = 0.112^B^). There was an interaction between hypoxia and CO~2~ clamp on PcCO~2~ (interaction: *P* = 0.018). Post hoc *t*-tests showed that hypoxia lowered PcCO~2~ during the unclamped condition (*P* = 0.010^B^ vs. normoxia) but not during the clamped condition (*P* = 0.630^B^), whereas CO~2~ clamping increased PcCO~2~ in hypoxia (*P* = 0.001^B^ vs. control) but not in normoxia (*P* = 0.035^B^). Meanwhile, both resting PcO~2~ and ScO~2~ were lowered with hypoxia (*P* = 0.001). CO~2~ clamping elevated PcO~2~ during both normoxia and hypoxia (*P* \< 0.002) and elevated ScO~2~ in hypoxia (post hoc: *P* = 0.016^B^), but not in normoxia (*P* = 0.115^B^, interaction: *P* = 0.024). Resting CcO~2~ was lower with hypoxia (*P* = 0.010), but unaffected with CO~2~ clamping (*P* = 0.221).

Time trial
----------

### Cycling performance

Exercise performance was impaired by 19 ± 7% in hypoxia (1899 ± 69 vs. 1584 ± 62 sec, hypoxia vs. normoxia, *P* \< 0.001), while there was a nonsignificant trend for CO~2~ clamping to exert a greater effect on exercise time in hypoxia compared to normoxia (CO~2~: *P* = 0.262, interaction: *P* = 0.097). Nevertheless, post hoc analysis revealed no significant improvement in the exercise time with CO~2~ clamping in hypoxia (1875 ± 72 vs. 1924 ± 5 sec, CO~2~ clamp vs. control; *P* = 0.108^B^) or normoxia (1589 ± 62 vs. 1579 ± 66 sec; *P* = 0.586^B^). Hypoxia lowered mean power, speed, and cadence (*P* \< 0.001, *P* \< 0.001, and *P* = 0.004, respectively) compared to normoxia, whereas no difference was observed with CO~2~ clamping (*P* = 0.468, *P* = 0.0694, and *P* = 0.656).

### Rate of perceived exertion

The participants' RPE during the time trial, as indicated by the Borg score, was higher in hypoxia (hypoxia: *P* = 0.009), but no difference was observed with CO~2~ clamping (clamp: *P* = 0.459).

### Respiratory variables

V\'E was elevated by both hypoxia and CO~2~ clamping (hypoxia: *P* = 0.048, clamp: *P* = 0.023), whereas PETO~2~ was lowered with hypoxia and elevated with CO~2~ clamping throughout the exercise (main effects: *P* \< 0.001 for both) ([Fig. 1](#fig01){ref-type="fig"}). Meanwhile, PETCO~2~ was lower with hypoxia during control only (*P* \< 0.001^B^), whereas CO~2~ clamping restored PETCO~2~ to the values observed in the normoxic clamped condition (*P* = 0.269^B^, interaction: *P* \< 0.001). SpO~2~ was lower during exercise in hypoxia during both control and clamped conditions (*P* \< 0.001^B^ for both), whereas SpO~2~ was higher with CO~2~ clamping during exercise in hypoxia (*P* \< 0.001^B^), but not normoxia (*P* = 0.713^B^, interaction: *P* \< 0.001).

![Effect of hypoxia and CO~2~ clamping on respiratory variables during 15-km time trial cycling. Left panels, group data in normoxia (mean ± SD); right panels, group data in hypoxia. •, normoxia control; ○, normoxia CO~2~ clamp; ▪, hypoxia control; □, hypoxia CO~2~ clamp.](phy20001-e00066-f1){#fig01}

In normoxia, the participants began cycling at ∼63% VO~2~max at the start of time trial, which progressively increased to 78% at the 14th km, before a final sprint reaching 85% VO~2~max at the end of exercise. In contrast, during hypoxic conditions, the participants began cycling at 46% (normoxic) VO~2~max, and progressively increased to 57% at the end of the time trial. Overall, both VO~2~ and VCO~2~ were lower in hypoxia (*P* \< 0.001 for both), whereas CO~2~ clamping tended to elevate VCO~2~ but not VO~2~ (*P* = 0.064 and *P* = 0.603, respectively).

### Cerebrovascular variables

Both hypoxia and CO~2~ clamping elevated MCAv during exercise (by 26% and 9%, respectively; hypoxia: *P* \< 0.001, clamp: *P* = 0.024, interaction: *P* = 0.963) ([Fig. 2](#fig02){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Hypoxia elevated cerebral HHb during exercise and lowered cerebral O~2~Hb and delta Hb (*P* \< 0.001 for all). In contrast, CO~2~ clamping lowered HHb (*P* = 0.015) and elevated delta Hb during exercise (*P* = 0.047), whereas no difference was observed in O~2~Hb with clamping (*P* = 0.118). During the time trial cycling, cerebral DO~2~ was lower with hypoxia (*P* = 0.004) and elevated with CO~2~ clamping (*P* = 0.019, interaction: *P* = 0.911).

![Effect of hypoxia and CO~2~ clamping on cerebral variables during 15-km time trial cycling. Cerebral O~2~Hb and HHb are expressed at delta changes from normoxia (room air baseline). Left panels, group data in normoxia (mean ± SD); right panels, group data in hypoxia. •, normoxia control; ○, normoxia CO~2~ clamp; ▪, hypoxia control; □, hypoxia CO~2~ clamp.](phy20001-e00066-f2){#fig02}

### Cardiovascular variables

There was a nonsignificant trend for MAP to be higher with CO~2~ clamping (*P* = 0.062), whereas no effect was observed with hypoxia (*P* = 0.535). No differences were observed in HR with hypoxia (*P* = 0.206) or CO~2~ clamping (*P* = 0.196).

### Muscle oxygenation

The effect of CO~2~ clamping on muscle O~2~Hb and delta Hb was greater in hypoxia compared to normoxia (interaction: *P* = 0.039 and *P* = 0.007, respectively) and tended to be greater for muscle HHb (interaction: *P* = 0.078) ([Fig. 3](#fig03){ref-type="fig"}). As a result, post hoc analysis revealed that hypoxia lowered muscle O~2~Hb and delta Hb during control condition (*P* \< 0.001^B^ vs. normoxia), and by a lesser extend during CO~2~ clamped condition for muscle delta Hb (*P* = 0.002^B^). Meanwhile hypoxia did not alter muscle O~2~Hb in the CO~2~ clamped condition (*P* = 0.033^B^ vs. control). CO~2~ clamping did not alter muscle O~2~Hb in normoxia (*P* = 0.554^B^), but tended to elevate it in hypoxia (*P* = 0.013^B^). Hypoxia during exercise elevated muscle HHb in both control and clamped conditions (*P* = 0.001^B^ and *P* = 0.008^B^ vs. normoxia, respectively), whereas there was a tendency for CO~2~ clamping to elevate muscle HHb during normoxia (*P* = 0.067^B^ vs. control) but not during hypoxia (*P* = 0.460^B^).

![Effect of hypoxia and CO~2~ clamping on muscle oxygenation during 15-km time trial cycling. Muscle O~2~Hb and HHb are expressed at delta changes from normoxia (room air baseline). Left panels, group data in normoxia (mean ± SD); right panels, group data in hypoxia. •, normoxia control; ○, normoxia CO~2~ clamp; ▪, hypoxia control; □, hypoxia CO~2~ clamp.](phy20001-e00066-f3){#fig03}

During exercise, EMG RMS increased slightly, in parallel with power output, showing a more pronounced increase during the end spurt (*P* \< 0.001). EMG RMS was lower in hypoxia compared to normoxic exercise (*P* = 0.002), whereas no difference was observed with CO~2~ clamping (*P* = 0.628).

### Blood gas variables

CO~2~ clamping during exercise elevated PcCO~2~ by a greater extent in hypoxia compared to normoxia (interaction: *P* \< 0.001) ([Table 2](#tbl2){ref-type="table"}). Accordingly, post hoc analysis revealed that CO~2~ clamping elevated PcCO~2~ during both normoxia (*P* \< 0.001^B^ vs. control) and hypoxia (*P* = 0.004^B^), whereas hypoxia lowered PcCO~2~ during control (*P* = 0.001^B^ vs. normoxia) but no difference was observed between clamped values of PcCO~2~ between normoxia and hypoxia (*P* = 0.526^B^). Hypoxia lowered PcO~2~ and CcO~2~ during exercise (hypoxia: *P* \< 0.001 for both), whereas CO~2~ elevated PcO~2~ (*P* \< 0.001) and tended to elevate CcO~2~ (*P* = 0.089). The effect of CO~2~ clamping on ScO~2~ was greater in hypoxia than normoxia (interaction: *P* = 0.006). Accordingly, hypoxia lowered ScO~2~ during both control and clamped conditions (post hoc: *P* \< 0.001^B^ vs. normoxia), whereas CO~2~ clamp elevated ScO~2~ during hypoxia (*P* = 0.005^B^ vs. control) but not during normoxia (*P* = 0.754^B^). No changes were observed in pH with either hypoxia (*P* = 0.568) or CO~2~ clamping during exercise (*P* = 0.182).

Discussion
==========

The well-documented detrimental effect of severe hypoxia on exercise performance is not fully understood. Several studies found a relationship between exercise capacity or performance and a reduction in cerebral oxygenation during various exercise modes in hypoxia, such as time trial cycling (Amann [@b2]; Amann et al. [@b5]), repeated sprints (Smith and Billaut [@b49]), incremental exercise (Subudhi et al. [@b50]; Peltonen et al. [@b38]), and static maximal muscle contraction to exhaustion (Rasmussen et al. [@b40]; Rupp and Perrey [@b43]; Vogiatzis et al. [@b57]; Goodall et al. [@b19]). These observations led to the hypothesis that the hyperventilation-induced hypocapnia and associated reduction in CBF and cerebral oxygenation may account for the impaired capacity and performance in hypoxia.

In this study, we tested the hypothesis that preventing the usual hyperventilation-induced hypocapnia and associated reduction in CBF and cerebral tissue oxygenation would improve 15-km time trial performance in severe normobaric hypoxia. Even though CBF was only increased by 9% during the hypoxic time trial with CO~2~ clamping, it resulted, with the concomitant 9% increase in SpO~2~ ([Figs. 2](#fig02){ref-type="fig"}), in significantly increased cerebral DO~2~ by 20% compared to the nonclamped control ([Table 2](#tbl2){ref-type="table"}). Importantly, this increase with CO~2~ clamping in hypoxia was sufficient to *normalize* cerebral DO~2~ to levels similar as observed during nonclamped normoxic exercise. As exercise performance in hypoxia was not significantly improved with clamping, it follows that the reduction in overall cerebral O~2~ delivery is not a prime reason for the reduced exercise performance in hypoxia.

Exercise in hypoxia
-------------------

The detrimental effects of decreases in CaO~2~ on endurance capacity of large muscle groups are well documented (Adams and Welch [@b1]; Koskolou and McKenzie [@b29]; Peltonen et al. [@b37]; Amann [@b2]; Amann et al. [@b5], [@b6]). In this study, we found a 9--29% reduction in exercise performance during 15-km time trial cycling in severe hypoxia due to a decreased motor drive (∼16% reduction in right vastus lateralis EMG RMS). In agreement with the results from Amann et al. ([@b5]), we found that markedly different strategies were employed during time trial exercise in normoxia and hypoxia. Specifically, during the time trial in normoxia, the participants slightly increased their power output throughout the 15 km, reaching maximal power at the end of exercise in the form of an end spurt. In contrast, during the time trial in hypoxia, participants began cycling at a relatively high power output, slightly lowering work rate throughout the exercise test, only increasing power output again toward the end with a short sprint over the last 100 m. Interestingly, this progressive decline in central motor drive and power output occurred despite relatively stable CcO~2~, ScO~2~, and muscle \[O~2~Hb\] during the time trial in hypoxia ([Table 2](#tbl2){ref-type="table"} and [Fig. 3](#fig03){ref-type="fig"}). Meanwhile, both cerebral \[O~2~Hb\] and cerebral DO~2~ remained relatively stable despite parallel increases in MCAv and cerebral \[HHb\] ([Fig. 2](#fig02){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). As this decline in power coincided with an increase in perceived exertion, we tentatively interpret these findings as supporting the role of inhibitory feedback of muscle afferents in limiting central motor drive during exercise in severe hypoxia (Amann et al. [@b5]).

CO~2~ clamping effects on CBF and prefrontal cerebral oxygenation
-----------------------------------------------------------------

Our aim was to improve CBF during exercise by adding CO~2~ to the inspirate~,~ clamping PETCO~2~ to 45 mmHg, preventing the normal hyperventilation-induced hypocapnia and associated cerebral vasoconstriction, while not influencing muscle oxygen supply. As expected, CO~2~ clamping in normoxia prevented the development of hypocapnia during the second half of the time trial, thereby elevating CBF ([Fig. 2](#fig02){ref-type="fig"}). During CO~2~ clamping in hypoxia, we were successful in elevating and maintaining PETCO~2~ stable at levels similar to those in normoxia ([Fig. 1](#fig01){ref-type="fig"}), without any development of respiratory acidosis ([Table 2](#tbl2){ref-type="table"}). However, despite a relatively greater hypercapnic stimulus, we observed only modest elevations in MCAv during exercise with CO~2~ clamping in hypoxia ([Fig. 2](#fig02){ref-type="fig"}). In this study, MCAv increased despite relatively stable MAP, cardiac output (not reported), pH, and PcO~2~ during exercise in hypoxia ([Fig. 2](#fig02){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}). Therefore, it seems unlikely that changes in perfusion pressure or circulating systemic stimuli (such as arterial hypoxemia) could account for the progressive rise in CBF during time trial cycling observed in hypoxia. Instead, we suspect that the increase in CBF is likely driven by other factors such as increased neural activity and cerebral metabolic demand associated with prolonged aerobic exercise in normobaric hypoxia.

Control of CBF during hypoxic exercise
--------------------------------------

The entire capillary network of the brain is covered by extensions of astrocytes, which constitutes the blood--brain barrier (Secher et al. [@b46]). As such, O~2~ diffusion distance plays a vital role during increased neural activation and subsequent increased O~2~ consumption. As there is no capillary recruitment in the brain, greater CBF is required to elevate the O~2~ gradient (Secher et al. [@b46]). Acute hypoxic exposure at rest elevates right prefrontal cortex activity (Schneider and Strüder [@b45]), and enhances O~2~ extraction in the brain (Ho et al. [@b21]). Meanwhile, studies of dynamically exercising humans have found that the increases in regional MCAv (and CBF) are driven by increased cortical activation of sensorimotor areas associated with neural input from the working limbs (Friedman et al. [@b16], [@b17]; Jorgensen et al. [@b26]). These observations support earlier findings in exercising dogs, of CBF redistribution to sensorimotor cerebral cortex, spinal cord, and cerebellum -- primarily in cortical layers (Gross et al. [@b20]). Accordingly, we attribute the higher MCAv observed in this study to greater sensorimotor cortex activation associated with exercise in hypoxia. Despite a considerably lower power output, we observed higher rates of perceived effort during exercise in hypoxia when compared to normoxia, thereby confirming reports of a direct effect of hypoxia on effort perception during exercise in severe hypoxia (Amann et al. [@b6]). Taken together, we postulate that elevated cerebral metabolism associated with greater sensorimotor cortex activation -- as indicated by higher perceived effort -- could account for the elevated CBF observed during exercise in severe hypoxia.

Cerebral oxygenation, oxygen delivery, and performance
------------------------------------------------------

Mass cerebral oxygen delivery is the product of CBF and CaO~2~. Therefore, it is important to consider the effect of CO~2~ clamping on CaO~2~. In this study, increased respiratory drive associated with CO~2~ clamping elevated PcO~2~ and ScO~2~, which in term tended to elevate CcO~2~ (*P* = 0.089, [Table 2](#tbl2){ref-type="table"}). Combined with modest elevations in MCAv during exercise ([Fig. 2](#fig02){ref-type="fig"}), we expected to see elevated mass O~2~ delivery to the brain with CO~2~ clamping in hypoxia. Instead, CO~2~ clamping in hypoxia normalized the cerebral DO~2~ to normoxic control values during time trial cycling ([Table 2](#tbl2){ref-type="table"}), which is supported by lower cerebral HHb and higher cerebral delta Hb ([Fig. 2](#fig02){ref-type="fig"}). Accordingly, we contend that we were successful in restoring cerebral DO~2~ during the time trial exercise in hypoxia with our CO~2~ clamping setup. Our data corroborate those of Subudhi et al. ([@b53]), who found significant increases in cerebral oxygenation with CO~2~ clamping during incremental exercise to capacity in hypoxia. We also found muscle oxygenation to be elevated with CO~2~ clamping in hypoxia ([Fig. 3](#fig03){ref-type="fig"}) -- presumably due to a higher SpO~2~ associated with increased ventilation ([Fig. 1](#fig01){ref-type="fig"}). As the restoration of cerebral DO~2~ with CO~2~ clamping in our study was not accompanied by improvements in exercise time, motor drive or mean power output, it appears that cerebral deoxygenation associated with hyperventilation-induced hypocapnia cannot account for the impaired performance in hypoxia. Intriguingly, this lack of improvement was observed despite a tendency for improvement of muscle tissue oxygenation with CO~2~ clamping in hypoxia. This lack of effect of increased cerebral O~2~ delivery on performance may be attributed, at least in part, to increased cerebral nonoxidative glycolysis during exercise in hypoxia (Overgaard et al. [@b35]). Furthermore, it is important to acknowledge that changes in global cerebral DO~2~ may not be representative of changes in local arterial and/or capillary [Po]{.smallcaps}~2~ in the brain; therefore, it is possible that we were unable to restore oxygen diffusion drive to the mitochondria of especially active neuronal tissue with our CO~2~ clamping setup.

Methodological considerations
-----------------------------

Some technical considerations should be acknowledged when interpreting our data. Prefrontal lobe oxygenation was used to represent global changes in cerebrocortical oxygenation. Subudhi et al. ([@b52]) have reported good correlations in oxygenation measurements between prefrontal, premotor, and motor cortices during maximal exercise. Therefore, we considered prefrontal oxygenation as an appropriate index of global changes in cerebrocortical oxygenation. Another important issue associated with NIRS is the influence of extracerebral and fat layers on the brain and muscle measurements, respectively (Cooper et al. [@b11]). Cerebral \[O~2~Hb\] measurements may be influenced by external carotid blood flow (Li et al. [@b30]) and forehead skin blood flow (Takahashi et al. [@b54]) during rest or a verbal fluency task, respectively. Nevertheless, Subudhi et al. ([@b53]) reported significant elevations in cerebral \[O~2~Hb\] and CBF with CO~2~ clamping during exercise in normoxia and hypoxia. Likewise, we found cerebral \[HHb\] to be lower with CO~2~ clamping, whereas cerebral \[O~2~Hb\] tended to be elevated in the last 5 km of exercise during CO~2~ clamping in normoxia and throughout exercise in hypoxia, coinciding with a higher MCAv ([Fig. 2](#fig02){ref-type="fig"}). Therefore, we contend that the NIRS methodology used in this study was sensitive enough to detect the changes in cerebral oxygenation associated with CO~2~ clamping.

An important limitation of this study, as of many other studies, is the assumption that MCAv represents global CBF changes. Four lines of evidence support the use of MCAv as an index of global CBF during exercise: (i) MCAv reflects change in internal carotid blood flow during dynamic exercise in both normoxia (Sato et al. [@b44]) and hypoxia (Huang et al. [@b22]); (ii) increases in MCAv are matched by increases in cortical CBF during dynamic exercise (Jorgensen et al. [@b26],[@b27]); (iii) whereas cortical representation of leg muscle can be served from measuring blood flow velocity of the anterior cerebral artery (van der Zwan and Hillen [@b59]), cortical representation of muscle involved in cycling is served dominantly by MCA (Jorgensen et al. [@b26]); (iv) the cross-sectional area of the MCA remains unchanged within a wide range of changes in PETCO~2~ (Bradac et al. [@b8]; Giller et al. [@b18]; Valdueza et al. [@b55]; Serrador et al. [@b47]); and (v) the diameter of MCA, as measured using TCD, remains relatively unchanged at 5300 m (5.23 mm) compared to sea level (5.30 mm) (Wilson et al. [@b58]). Accordingly, we contend that MCAv is a reasonable index of changes in global CBF during heavy exercise in hypoxia. Nevertheless, we acknowledge that changes in CBF and cerebral metabolic activity during exercise and with hypoxia are not homogeneous. In this study, the assessment of CBF and cerebral tissue oxygenation was limited to the MCA and the left prefrontal cortex, respectively, which were taken as global indices. However, it is likely that certain brain regions are more metabolically active and others regions are less active during exercise in hypoxia.

Another limitation of this study is that we clamped end-tidal rather than arterial P[co]{.smallcaps}~2~ during exercise. As the end-tidal--arterial P[co]{.smallcaps}~2~ gradient (Robbins et al. [@b42]) varies with exercise (Jones et al. [@b25]; Liu et al. [@b31]), it is possible that we did not clamp arterial P[co]{.smallcaps}~2~ per se. In this study, we measured arterialized capillary blood samples, as a surrogate of arterial measurements, and were able to clamp and maintain capillary P[co]{.smallcaps}~2~ within 1 mmHg throughout exercise under both normoxic and hypoxic conditions. As Mollard et al. ([@b33]) found good correlations between prewarmed capillary earlobe samples with radial artery measurements of [Po]{.smallcaps}~2~ (*R*^2^ = 0.99), P[co]{.smallcaps}~2~ (*R*^2^ = 0.86), and SO~2~ (*R*^2^ = 0.99) during rest, submaximal, and near maximal exercise intensities, we are confident that our protocol was effective in clamping and maintaining arterial P[co]{.smallcaps}~2~.

Finally, lack of power could potentially limit the interpretation of the tendency (*P* = 0.108) for performance to be improved with CO~2~ clamping in hypoxia. However, this seems unlikely as power calculation using Gaussian approximation revealed a power of 0.95 for our post hoc *t*-test. Furthermore, given the results from the earlier studies using an incremental exercise paradigm (Subudhi et al. [@b53]; Siebenmann et al. [@b48]) and the rather small effect, if any, found in this study, the tested hypothesis should be refuted.

Conclusion
==========

We were unable to improve exercise performance in severe hypoxia, despite a normalization of cerebral oxygen delivery to normoxia values and higher cerebral and muscle oxygenation. The hypothesis that the hyperventilation-induced hypocapnia and the subsequent drop in cerebral oxygenation are the cause of the reduced endurance exercise performance in hypoxia is thus refuted. Our data demonstrate that CBF is progressively elevated during time trial cycling in normobaric hypoxia, which appears to be independent of changes in perfusion pressure, cardiac output, or partial pressure of arterial CO~2~ and O~2~. We speculate that this increase in CBF during prolonged submaximal exercise in hypoxia may be due to either greater somatosensory input, increased motor drive output, or both.
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